#CNBC Major pharmaceutical companies are already investing in U.S. manufacturing: Guggenheim’s Divan

Major pharmaceutical companies are already investing in U.S. manufacturing: Guggenheim’s Divan
Vamil Divan, Guggenheim Partners senior pharma analyst, joins ‘Power Lunch’ to discuss how many pharma giants have U.S. production capabilities, how to factor in the generic drug stipulation and much more.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”